Observational studyHepatology communications2026
The INTEGRATE prospective cohort study: Design and methods to evaluate biopsychosocial determinants of outcomes in early liver transplantation for alcohol-associated liver disease.
Observational study in Hepatology communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND AND
aimsEarly liver transplantation (eLT) for alcohol-associated liver disease (ALD), defined as transplant evaluation with <6 months of alcohol abstinence, is a life-saving therapy for select patients. However, critical gaps remain in understanding patient selection, management strategies, and longitudinal outcomes. To address these gaps, the multi-disciplinary INTEGRATE Collaborative was established to conduct 5 parallel studies using a mixed-methods research approach to comprehensively address these gaps. This manuscript describes the design and methods of the INTEGRATE cohort study, which aims to identify the biopsychosocial factors causally related to and predictive of stakeholder-relevant outcomes. METHODS AND
resultsThe INTEGRATE cohort study is a prospective multicenter, longitudinal, observational study enrolling up to 680 adults with ALD undergoing evaluation for eLT at 4 U.S. centers. Participants are followed from transplant evaluation initiation through key pre-transplant and post-transplant milestones, with planned outcome surveillance for a minimum of 36 months, and longer as data are available. Data collection includes detailed alcohol use assessments, psychosocial and behavioral measures, clinical data, imaging, and biospecimen banking. The cohort is designed to identify biopsychosocial factors associated with and predictive of survival, waitlisting, alcohol-associated outcomes, healthcare utilization, and post-transplant clinical and patient-reported outcomes.
conclusionsThe prospective INTEGRATE cohort study provides a rigorous observational foundation to inform patient selection, management, and outcome prediction in eLT for ALD. This method's manuscript details the cohort design to promote transparency, reproducibility, and integration with complementary INTEGRATE studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.